Q12866 (MERTK_HUMAN) Homo sapiens (Human)

Tyrosine-protein kinase Mer UniProtKBInterProSTRINGInteractive Modelling

999 aa; Sequence (Fasta)

Available Structures

36 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of the Mer kinase domain in complex with a macrocyclic inhibitorhomo-2-mer572-864
7YS;
Assess
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp…homo-2-mer576-863
CL;9VS;MG;
Assess
Apo crystal structure of the MerTK kinase domainmonomer571-862
CL;
Assess
Crystal structure of MerTK kinase domain in complex with LDC1267monomer571-862
R6H;CL;
Assess
Crystal structure of MerTK kinase domain in complex with UNC2025monomer571-862
R6N;CL;DMS;
Assess
Crystal structure of MerTK kinase domain in complex with Merestinibmonomer571-862
L1X;CL;
Assess
MerTK kinase domain with type 1.5 inhibitor containing a di-methyl pyrazole groupmonomer571-862
VJZ;CL;DMS;
Assess
MerTK kinase domain in complex with purine inhibitormonomer571-862
S4Q;
Assess
Crystal structure of MerTK kinase domain in complex with Gilteritinibmonomer571-862
C6F;CL;DMS;
Assess
MerTK kinase domain with type 1.5 inhibitor containing a tri-methyl pyrazole groupmonomer571-862
VK5;CL;
Assess
MerTK kinase domain in complex with a type 2 inhibitormonomer571-862
S4T;
Assess
MerTK kinase domain with type 1 inhibitor from a DNA-encoded librarymonomer571-862
S4Z;
Assess
MerTK kinase domain in complex with a bisaminopyrimidine inhibitormonomer571-862
S4N;
Assess
MerTK kinase domain with type 1.5 inhibitor from a DNA-encoded librarymonomer571-862
S4W;
Assess
MerTK kinase domain with type 1.5 inhibitor containing a di-methyl, cyano pyrazole groupmonomer571-862
VK2;CL;DMS;
Assess
Crystal structure of MerTK Kinase domain with BMS794833monomer571-862
E0X;CL;DMS;
Assess
Crystal structure of MerTK in complex with a type 1.5 aminopyridine inhibitormonomer574-863
R6K;CL;EDO;
Assess
Kinase domain of MERTK in complex with compound 8monomer575-863
EDO;
Assess
Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex …monomer575-863
OLP;
Assess
Fragment-based Lead Discovery of Indazole-based Compounds as AXL Kinase Inhibitorsmonomer575-863
E56;
Assess
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp…monomer576-863
CL;K0X;
Assess
MerTK kinase domain in complex with quinazoline-based inhbitormonomer576-863
S4E;SO4;
Assess
Crystal structure of catalytic domain of the proto-oncogene tyrosine-protein kinase MER in complex …monomer575-861
CL;MG;ADP;GOL;
Assess
MerTK kinase domain with type 3 inhibitor from a DNA-encoded librarymonomer576-862
S5E;CL;EDO;
Assess
Catalytic Domain of the Proto-oncogene Tyrosine-protein Kinase MERmonomer575-861
MG;ANP;BME;
Assess
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp…monomer577-863
CL;6Q1;
Assess
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp…monomer577-863
CKJ;CL;CA;
Assess
MerTK kinase domain in complex with NPS-1034monomer577-862
S4K;
Assess
Crystal Structure of the MerTK Kinase Domain in Complex with Inhibitor MIPS15692monomer577-862
YR7;
Assess
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp…monomer577-861
CL;MG;MH7;
Assess
Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Me…monomer577-861
7AE;
Assess
Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Me…monomer578-861
79Y;
Assess
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp…monomer580-863
CL;4MH;
Assess
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp…monomer578-861
CL;YDJ;
Assess
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase MER in comp…monomer578-861
CL;MG;24K;
Assess
Solution structures of the fn3 domain of human Proto-oncogene tyrosine-protein kinase MER precursormonomer373-483
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
5u6b.2.Amonomer0.75566-862
68.67
Assess